Citigroup’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.79M | Sell |
29,701
-1,142
| -4% | -$256K | ﹤0.01% | 1722 |
|
|
2025
Q4 | $6.58M | Buy |
30,843
+8,532
| +38% | +$1.76M | ﹤0.01% | 1821 |
|
|
2025
Q3 | $4.44M | Sell |
22,311
-3,788
| -15% | -$707K | ﹤0.01% | 2056 |
|
|
2025
Q2 | $4.5M | Buy |
26,099
+4,935
| +23% | +$804K | ﹤0.01% | 1981 |
|
|
2025
Q1 | $3.3M | Buy |
21,164
+116
| +0.6% | +$16.6K | ﹤0.01% | 2274 |
|
|
2024
Q4 | $2.9M | Sell |
21,048
-220
| -1% | -$28.9K | ﹤0.01% | 2490 |
|
|
2024
Q3 | $3.18M | Sell |
21,268
-4,013
| -16% | -$542K | ﹤0.01% | 2255 |
|
|
2024
Q2 | $3.45M | Buy |
25,281
+5,305
| +27% | +$722K | ﹤0.01% | 1902 |
|
|
2024
Q1 | $3.02M | Buy |
19,976
+952
| +5% | +$136K | ﹤0.01% | 2086 |
|
|
2023
Q4 | $2.4M | Sell |
19,024
-13,553
| -42% | -$1.35M | ﹤0.01% | 2085 |
|
|
2023
Q3 | $3.05M | Buy |
32,577
+8,257
| +34% | +$772K | ﹤0.01% | 1716 |
|
|
2023
Q2 | $2.17M | Sell |
24,320
-9,368
| -28% | -$815K | ﹤0.01% | 2140 |
|
|
2023
Q1 | $3.61M | Buy |
33,688
+14,913
| +79% | +$1.71M | ﹤0.01% | 1665 |
|
|
2022
Q4 | $2.29M | Buy |
18,775
+17,496
| +1,368% | +$2.03M | ﹤0.01% | 1932 |
|
|
2022
Q3 | $132K | Sell |
1,279
-318
| -20% | -$30.1K | ﹤0.01% | 3965 |
|
|
2022
Q2 | $149K | Sell |
1,597
-306
| -16% | -$28.8K | ﹤0.01% | 4005 |
|
|
2022
Q1 | $223K | Sell |
1,903
-534
| -22% | -$61.8K | ﹤0.01% | 4029 |
|
|
2021
Q4 | $328K | Sell |
2,437
-1,111
| -31% | -$165K | ﹤0.01% | 4067 |
|
|
2021
Q3 | $566K | Sell |
3,548
-200
| -5% | -$27.4K | ﹤0.01% | 3523 |
|
|
2021
Q2 | $493K | Buy |
3,748
+2,408
| +180% | +$321K | ﹤0.01% | 3731 |
|
|
2021
Q1 | $173K | Sell |
1,340
-531
| -28% | -$80.7K | ﹤0.01% | 4083 |
|
|
2020
Q4 | $312K | Sell |
1,871
-898
| -32% | -$148K | ﹤0.01% | 4623 |
|
|
2020
Q3 | $427K | Sell |
2,769
-472
| -15% | -$67.8K | ﹤0.01% | 3986 |
|
|
2020
Q2 | $479K | Buy |
3,241
+422
| +15% | +$57.9K | ﹤0.01% | 4302 |
|
|
2020
Q1 | $317K | Sell |
2,819
-736
| -21% | -$95.6K | ﹤0.01% | 4300 |
|
|
2019
Q4 | $495K | Buy |
3,555
+2,354
| +196% | +$262K | ﹤0.01% | 4430 |
|
|
2019
Q3 | $116K | Buy |
1,201
+154
| +15% | +$17.2K | ﹤0.01% | 5561 |
|
|
2019
Q2 | $121K | Buy |
1,047
+454
| +77% | +$54.3K | ﹤0.01% | 5692 |
|
|
2019
Q1 | $70K | Buy |
+593
| New | +$51.9K | ﹤0.01% | 6061 |
|
|
2018
Q2 | – | Sell |
-142
| Closed | -$9K | – | 7595 |
|
|
2018
Q1 | $9K | Sell |
142
-902
| -86% | -$50.7K | ﹤0.01% | 7072 |
|
|
2017
Q4 | $42K | Buy |
+1,044
| New | +$38K | ﹤0.01% | 6290 |
|
|
2016
Q2 | – | Sell |
-50
| Closed | -$1K | – | 7062 |
|
|
2016
Q1 | $1K | Buy |
+50
| New | +$888 | ﹤0.01% | 7272 |
|
|
2015
Q3 | – | Sell |
-42
| Closed | -$1K | – | 7358 |
|
|
2015
Q2 | $1K | Sell |
42
-38
| -48% | -$665 | ﹤0.01% | 7265 |
|
|
2015
Q1 | $1K | Buy |
+80
| New | +$1.46K | ﹤0.01% | 7023 |
|
Other funds holding ASND
RCM
ACA
